Experiments in social responsibility
Pursuing drugs for neglected diseases is not a traditional part of the pharmaceutical company portfolio. But Paul Herrling of Novartis finds that it...
News Center
The New World of Global Health
An array of well-heeled new players has dramatically reshaped how wealthy countries tackle infectious diseases of the poor. But increasingly, these am...
TB Alliance and KRICT Renew Their Agreement to Develop Novel Quinolone Compounds for TB: Several Promising Compounds Already Identified
The TB Alliance and the Korean Research Institute of Chemical Technology (KRICT) recently renewed their Agreement to develop novel quinolone compounds...
12/01/2005Continue Reading >
Time Summit Brings Together Leaders in Global Health to Discuss New Approaches to Diseases such as TB and AIDS
From November 1-3, Time Magazine convened leaders in medicine, government, business and public policy to discuss critical issues concerning global hea...
12/01/2005Continue Reading >
Statement by Affected Communities Calls for Massively Accelerated Research to Develop New Tools
On October 23rd, at the 36th World Congress on Lung Health in Paris, a group of individuals and organizations from communities affected by TB presente...
12/01/2005Continue Reading >
Four Groups Join the TB Alliance Stakeholders Association
On October 17, 2005, at the TB Alliance’s Annual Stakeholders Association Meeting in Paris, members approved the addition of four new organizati...
12/01/2005Continue Reading >
TB Alliance Board of Directors Appoints Two New Members
At its October 2005 Board Meeting, the TB Alliance Board of Directors appointed two new Board members to three-year terms: Mr. Mark Kessel of New York...
Dr. Maria C. Freire Addresses Time Summit on Global Progress Toward TB Control
On November 2, 2005, at the Time Summit, Dr. Maria C. Freire, President & CEO of the TB Alliance participated in a panel discussion entitled &ldqu...
11/02/2005Continue Reading >
Rural Doctor Contends With a TB Outbreak
My pregnant 25-year-old patient was understandably concerned when her tuberculosis (TB) skin test came back positive. Her brother had died of lung pro...
Trials Target TB
PARIS--The amount of time required to treat tuberculosis (TB) could be halved if a series of phase II clinical trials of a new drug regimen, announced...
News Center Search
Press Contact: press@tballiance.org
TB Alliance Publications
Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis
New TB Regimens: What Countries Want
Pathway to Patients
Policy on the Compassionate / Emergency Use of Experimental TB Alliance Drugs
TB In The News
Site by Darby Communications
© 2013 Global Alliance for TB Drug Development